Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.

Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.

Show other versions (1)

As part of its single technology appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited the manufacturer of rituximab (Roche Products) to submit evidence of the clinical and cost effectiveness of rituximab in combination with corticosteroids for treatment of an...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Latimer, N, Carroll, C, Wong, R, Tappenden, P, Venning, M, Luqmani, R
פורמט:	Journal article
שפה:	English
יצא לאור:	2014

פריטים דומים

Rituximab in Combination with Corticosteroids for the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A NICE Single Technology Appraisal
מאת: Latimer, N, et al.
יצא לאור: (2014)

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.
מאת: Guerry, M, et al.
יצא לאור: (2012)

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
מאת: Flossmann, O, et al.
יצא לאור: (2006)

Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis
מאת: Michael A Paley, et al.
יצא לאור: (2019-01-01)

Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis
מאת: Robson, J, et al.
יצא לאור: (2017)

Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis.
מאת: Basu, N, et al.
יצא לאור: (2014)

Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis
מאת: Pearce, F, et al.
יצא לאור: (2017)

Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis
מאת: Thomas Hellmark, et al.
יצא לאור: (2019-03-01)

Anti-neutrophil cytoplasmic antibody associated vasculitis following rituximab: Outcomes of 50 patients in a tertiary single centre
מאת: Fahidah Alenzi, et al.
יצא לאור: (2023-09-01)

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
מאת: Valentina Binda, et al.
יצא לאור: (2021-12-01)

Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)–Associated Vasculitis
מאת: Alan D. Salama
יצא לאור: (2020-01-01)

Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
מאת: Cheng-Hua Weng, et al.
יצא לאור: (2019-12-01)

A disease-specific patient-reported outcome for anti-neutrophil cytoplasmic antibody–associated vasculitis: scale structure and measurement properties of the anti-neutrophil cytoplasmic antibody-associated vasculitis patient-reported outcome measure
מאת: Robson, J, et al.
יצא לאור: (2017)

Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
מאת: Saket Jha, et al.
יצא לאור: (2019-01-01)

Posterior scleritis with anti-neutrophil cytoplasmic antibody-associated vasculitis utilizing rituximab therapy to maintain remission: A case report
מאת: Xinyu Weng, et al.
יצא לאור: (2022-03-01)

Cardiovascular and Cerebrovascular Outcomes in Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis
מאת: Shiyu Xiao, et al.
יצא לאור: (2024-01-01)

Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
מאת: Christopher Maximilian Arends, et al.
יצא לאור: (2020-06-01)

Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis
מאת: Haiting Wu, et al.
יצא לאור: (2022-04-01)

A glance into the future of anti-neutrophil cytoplasmic antibody-associated vasculitis
מאת: Marta Casal Moura, et al.
יצא לאור: (2022-11-01)

Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody（ANCA）-associated vasculitis
מאת: Daisuke Tsukui, et al.
יצא לאור: (2021-01-01)

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
מאת: Hellmich, B, et al.
יצא לאור: (2007)

Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients
מאת: Laura S. van Dam, et al.
יצא לאור: (2020-12-01)

Use of a computerised system to facilitate evaluation of anti-neutrophil cytoplasm (ANCA Associated) vasculitis (AAV) and other forms of systemic vasculitis
מאת: Luqmani, R, et al.
יצא לאור: (2017)

The role of neutrophils in vasculitis associated with antineutrophil cytoplasmic antibodies
מאת: E. N. Vorkel, et al.
יצא לאור: (2024-12-01)

Application of biological agents in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis
מאת: Weijun Liu, et al.
יצא לאור: (2024-05-01)

Recent advances in the diagnosis and treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis
מאת: Si-wei Tang, et al.
יצא לאור: (2024-03-01)

Oral Microbiota Profile in Patients with Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis
מאת: Anders Esberg, et al.
יצא לאור: (2022-08-01)

Late Onset of Rivaroxaban-Associated Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis
מאת: Muskan Agarwal MD, et al.
יצא לאור: (2023-10-01)

A case of Sjögren syndrome and anti-neutrophil cytoplasmic antibody-associated vasculitis
מאת: K. Kaynar, et al.
יצא לאור: (2023-07-01)

Testicular granulomatous vasculitis mimicking testicular torsion in an anti-neutrophil cytoplasmic antibody–associated vasculitis patient
מאת: Liye Suo, et al.
יצא לאור: (2019-01-01)

Clinical significance of HEp-2 cell cytoplasmic patterns in anti-neutrophil cytoplasmic antibody associated vasculitis
מאת: Naidan Zhang, MS, et al.
יצא לאור: (2022-06-01)

Clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in French children
מאת: Salomon R, et al.
יצא לאור: (2011-09-01)

Anti-myeloperoxidase IgM B cells in anti-neutrophil cytoplasmic antibody-associated vasculitis
מאת: CM Wortel, et al.
יצא לאור: (2025-02-01)

Glucocorticoid Minimization in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An International Survey of Clinicians
מאת: David Massicotte-Azarniouch, et al.
יצא לאור: (2024-08-01)

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
מאת: Mukhtyar, C, et al.
יצא לאור: (2006)

Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
מאת: Zhi-Ying Li, et al.
יצא לאור: (2020-08-01)

Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
מאת: Moog P, et al.
יצא לאור: (2015-11-01)

Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis
מאת: Despina Michailidou, et al.
יצא לאור: (2022-06-01)

Positive predictive value of anti-neutrophil cytoplasmic antibody (ANCA) testing for ANCA-associated systemic vasculitis (AASV) in a routine clinical setting
מאת: McLaren, J, et al.
יצא לאור: (2001)

Anti-neutrophil cytoplasmic antibody–associated vasculitis complicated with diffuse alveolar haemorrhage and central nervous system vasculitis
מאת: Takashi Nawata, et al.
יצא לאור: (2021-04-01)